About this event

  • Date and time Mon 28 Nov 2022 from 6:00pm to 8:15pm
  • Location Royal Society of Medicine
  • Organised by Public Engagement Programme, The Howard Foundation

Free for all

Join us for the Howard Foundation 40th anniversary lecture focusing on prostate cancer. After the lecture, you are invited to join us for a drinks reception to network, relax and enjoy a refreshing drink in the RSM's iconic glass atrium.

According to statistics presented by Cancer Research UK, prostate cancer is the most common type of cancer among men in the UK with more than 52,000 new cases per year with incidence rates increasing by almost 50% since the early 1990s and projected to keep rising by 12% to 233 cases per 1,000 males by 2035. 

Professor Mark Emberton, Professor of Intervention Oncology and Dean, Faculty of Medical Science at University College London, will provide an insightful presentation reflecting on the transformation of prostate cancer management within the last 10 years.

Dr Matthew Hobbs, Director of Research at Prostate Cancer UK, will also join us to say a few words about the work of the charity prioritising investing in treatment and testing.

The RSM would like to thank The Howard Foundation for their support of this hybrid event.

Dr Alan Howard (1929-2020)

Born in Norwich in 1929, Alan Howard won a scholarship to Downing College Cambridge in 1948, gaining his MA and PhD in 1955. He spent over 70 years connected with Downing as a student, researcher, teacher and benefactor.

Dr Howard became a leading scientist in the fields of atherosclerosis, obesity and latterly nutrition. He published extensively, was a writer and editor of books and journals, and organiser of international conferences.

He is most widely known as the inventor of a very low-calorie diet, known as the Cambridge Diet, the result of many years of research and clinical trials in the 1960s and 1970s. This became a patented formula that sold widely in America and Europe in the 1980s and continues to flourish today through the company he founded, now known as Cambridge Weightplan.

For the final 20 years of his life, Alan led research into the role of macular carotenoids on vision and memory, latterly working with the Waterford Institute of Technology in Ireland.

In 1982 he created an English charitable trust, the Howard Foundation, which has supported numerous scientific research projects. The Foundation has also donated generously to Downing College, enabling the construction of three buildings including a magnificent neoclassical theatre. His son Jon, and daughter Julie, lawyer and dietitian respectively, continue to run the Howard Foundation alongside two other Trustees.

Dr Howard died aged 91 in June 2020. His legacy continues with both the work of the Howard Foundation and BON, the Brain and Optical Nutrition network of scientists

Follow us on:

Facebook
Instagram
LinkedIn
Twitter
YouTube

Show Virtual / In Person rates

Key speakers

Mark Emberton

Professor Mark Emberton

Professor of Intervention Oncology and Dean, Faculty of Medical Science, University College London

Speaker's biography

Mark Emberton is Professor of Intervention Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London.  He is clinically active and holds the position of Honorary Consultant Urologist at University College London Hospitals NHS Trust where he works as a specialist in prostate cancer. 

 

His academic work has focused on developing novel diagnostic strategies and new therapies for men with prostate cancer.  His research has resulted in the transformation of both the diagnostic and therapeutic pathways.  These have been incorporated into international guidelines.

 

He has published over 500 peer review papers, holds a large grant portfolio, and lectures widely around the world and holds international honorary professorships.

 

He is a founding Pioneer of the charity Prostate Cancer UK. 

Matt Hobbs

Dr Matthew Hobbs

Director of Research, Prostate Cancer UK

Speaker's biography

Dr Matthew Hobbs was appointed Director of Research in June 2020, having joined Prostate Cancer UK in 2013 as Deputy Director of Research. He is responsible for overseeing the ambitious research strategy, and making sure that only research with the best chance of making a difference for men is funded. Matthew leads the Prostate cancer UK research team: ensuring that the charity is fully informed about prostate cancer research happening around the world, identifying and investing in areas of the highest strategic importance, and making funding decisions based on sector-leading processes that exceed The Association of Medical Research Charities (AMRC) best practice guidance. He is well known across the medical research sector having provided informal advice to many other funders, and regularly collaborates with and delivers ‘masterclasses’ for the AMRC. He is also an elected Trustee of the National Cancer Research Institute.

 

Prior to his roles with Prostate Cancer UK Matthew was the Head of Research at Diabetes UK (2012-13), Senior Project Manager for the National Institute for Health and Care Research Manchester Biomedical Research Centre (2010-2012) and Knowledge Transfer Partner with Manchester Business School developing tools for the NHS to support commercial clinical trials (2009-2010). He has a PhD in Chemistry, and MChem in Chemistry with French, from the University of Liverpool.

 

Outside of work Matthew is a keen runner, currently chasing an elusive sub 3:20 marathon, and even keener purchaser of running shoes. He is a committed Evertonian, spending much of his spare time being bitter about Liverpool FC’s current success, and turning to American sports when English football becomes too depressing.

Agenda

View the programme

Registration, tea and coffee
Welcome and introduction

Professor Roger Kirby, President, Royal Society of Medicine, Ms Julie Lambert, Chair, Howard Foundation and Mr Jon Howard, Secretary, Howard Foundation

Seeing is believing – the transformation of prostate cancer management over the last decade

Professor Mark Emberton, Professor of Intervention Oncology and Dean, Faculty of Medical Science, University College London

Our eyes are open but where should we look next?

Dr Matthew Hobbs, Director of Research, Prostate Cancer UK

Question and answer session

Professor Roger Kirby, Professor Mark Emberton and Dr Matthew Hobbs

Closing remarks

Professor Roger Kirby

Close of meeting
Drinks reception

All welcome

View the programme

Welcome and introduction

Professor Roger Kirby, President, Royal Society of Medicine, Ms Julie Lambert, Chair, Howard Foundation and Mr Jon Howard, Secretary, Howard Foundation

Seeing is believing – the transformation of prostate cancer management over the last decade

Professor Mark Emberton, Professor of Intervention Oncology and Dean, Faculty of Medical Science, University College London

Our eyes are open but where should we look next?

Dr Matthew Hobbs, Director of Research, Prostate Cancer UK

Question and answer session

Professor Roger Kirby, Professor Mark Emberton and Dr Matthew Hobbs

Closing remarks

Professor Roger Kirby

Close of meeting

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Registration for this event will close on 27 November 2022 at 8:00am (GMT). Late registrations will not be accepted.

The agenda is subject to change at any time.

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.

We are only able to share presentations that we have received permission to share. This is at the presenter and the RSM’s discretion.

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.